Lobucavir

An antiviral drug candidate

Lobucavir
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Lobucavir is an antiviral drug that was developed for the treatment of various viral infections. It is a nucleoside analogue that inhibits viral DNA polymerase, thereby preventing viral replication.

Mechanism of Action

Lobucavir functions as a nucleoside analogue, which means it mimics the natural building blocks of DNA. When incorporated into viral DNA by the viral DNA polymerase, it causes premature chain termination. This effectively halts the replication of the virus, as the incomplete DNA cannot be used to produce new viral particles.

Development and Clinical Trials

Lobucavir was initially developed for the treatment of hepatitis B virus (HBV) and herpes simplex virus (HSV) infections. During its development, it showed promise in inhibiting the replication of these viruses in vitro and in early clinical trials.

Hepatitis B Virus

In studies involving patients with chronic hepatitis B, lobucavir demonstrated a reduction in viral load and improvement in liver function tests. However, further development was halted due to concerns about potential carcinogenicity observed in animal studies.

Herpes Simplex Virus

Lobucavir was also tested for efficacy against herpes simplex virus infections. It showed activity against both HSV-1 and HSV-2 in laboratory settings. Despite these promising results, the development for this indication was also discontinued.

Chemical Structure

Chemical structure of Lobucavir

Lobucavir is a synthetic analogue of the natural nucleoside guanosine. Its chemical structure allows it to be incorporated into viral DNA, where it acts as a chain terminator.

Potential Uses

Although lobucavir is not currently approved for clinical use, its mechanism of action suggests potential applications in treating other DNA virus infections. Research into similar compounds continues, with the aim of developing safer and more effective antiviral therapies.

Related Pages

• Antiviral drug
• Nucleoside analogue
• Hepatitis B virus
• Herpes simplex virus